The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis

International trends in antipsychotic use: A study in 16 countries, 2005–2014

(2017) Óskar Hálfdánarson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004–2013

(2015) Akshya Vasudev et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Concerns about quetiapine

(2015) Jonathan Brett   Australian Prescriber

Validation of a claims-based antipsychotic polypharmacy measure

(2014) Emily Leckman-Westin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Treatment of bipolar disorder

(2013) John R Geddes et al.   LANCET

Characteristics and trends of low-dose quetiapine use in two western state Medicaid programs

(2013) Daniel M. Hartung et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Off-Label Use of Atypical Antipsychotics

(2012) Andrew McKean et al.   CNS DRUGS

Medicaid Cost Control Measures Aimed At Second-Generation Antipsychotics Led To Less Use Of All Antipsychotics

(2011) William B. Vogt et al.   HEALTH AFFAIRS

Assessment of Changes in Utilization of Health-Care Services after Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents

(2010) Amy Walthour et al.   ANNALS OF PHARMACOTHERAPY

Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications

(2008) J FARLEY et al.   CLINICAL THERAPEUTICS

Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change

(2008) Stephen B. Soumerai et al.   HEALTH AFFAIRS

Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation

(2008) Surrey M Walton et al.   PHARMACOTHERAPY